Navigation Links
Cota Healthcare Announces Major Multi-Year Collaboration With Global Pharmaceutical Leader To Advance Innovative Therapies For Breast Cancer Patients

NEW YORK, March 27, 2017 /PRNewswire/ -- Cota Healthcare, the leading data and technology platform for value-based precision medicine, today announced the signing of a major, multi-year collaboration with Novartis Pharmaceuticals Corporation to help improve clinical and cost outcomes for breast cancer patients.

As part of this agreement, which expands significantly on the previous announced collaboration entered into January 2016, teams from across Novartis Pharmaceuticals Corporation will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and technology platform supplied by Cota is expected to enable Novartis Pharmaceuticals Corporation to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.

"Data and insight that comes directly from patient records - real-world evidence - is transforming how pharmaceutical and life science companies develop more precise, targeted therapies," said John Hervey, CEO of Cota. "Novartis has been an incredible collaborator over the last several years in adopting Cota's real-world evidence solutions to advance our shared goal of quantifiably improving and extending patient lives."

Cota's platform is powered by the patented Cota Nodal Address™ (CNA) system, a digital classification methodology that stratifies patients based on all the personal and clinical factors that matter to the individual. Each patient with the same CNA can be considered medically identical, and thus should have similar treatments and outcomes.

"We're excited about helping Novartis get deep insight into how patients are getting treatment in practice and connecting the dots all the way from patient to doctor to researcher," said Dr. Andrew Pecora, Founder & Executive Chairman of Cota. "Analyzing this data using CNAs is a critical factor in enabling healthcare companies to develop and target therapies that increase outcomes and lower the total cost of care."

About Cota Healthcare: 
Cota Healthcare is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.

Cota's technology enriches raw medical records to create research-grade data, and joins it with a suite of analysis, visualization, and management tools. This enables providers, payers, and life sciences companies to analyze, report on, and research outcomes, costs, treatments, and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and science to help improve the lives of patients everywhere.

Press Contact: Matthew Levin 
Phone: +1 (646) 543-2682

To view the original version on PR Newswire, visit:

SOURCE Cota Healthcare
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference on April 4th
2. Report: N.J. Hospitals Reduced Healthcare Costs by $641 Million Through Quality Improvement Initiative
3. Cantel Medical to Present at the 16th Annual Needham & Company Healthcare Conference
4. Frost & Sullivan Applauds GE Healthcares Visionary Innovation Strategy in Providing End-to-End Cardiac Diagnostic Solutions Globally
5. Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017
6. Healthcare Stocks on Investors Radar -- Depomed, Novartis AG, TherapeuticsMD, and Tonix Pharma
7. Intec Pharma to Participate in the Oppenheimer 27th Annual Healthcare Conference
8. Omron Healthcare Agrees on Equity Investment and Expansion of Business Partnership with AliveCor
9. Healthcare Stocks on Investors Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories
10. PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference
11. Roche Diagnostics recognizes Poplar Healthcare as Roche Molecular Center of Excellence
Post Your Comments:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology:
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):